IVL for Stent Underexpantsion
IVL-DRAGON
Intravascular Lithotripsy for the Treatment of Stent Underexpansion: the Multicenter IVL-DRAGON Registry
1 other identifier
observational
62
1 country
16
Brief Summary
The IVL-Dragon Registry was a multicenter study that enrolled consecutive patients with stent underexpansion treated with IVL in high-volume PCI centers. The primary efficacy endpoint was clinical success, defined as a reduction of stent underexpansion to \<30% with no evidence of in-hospital device-oriented composite end point (DOCE) (defined as a composite of cardiac death, target lesion revascularization, and target vessel myocardial infarction).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2019
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2021
CompletedFirst Submitted
Initial submission to the registry
October 19, 2021
CompletedFirst Posted
Study publicly available on registry
November 8, 2021
CompletedNovember 8, 2021
November 1, 2021
1.4 years
October 19, 2021
November 5, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical Success
Reduction of stent underexpansion to the value of \<30% with no evidence of in-hospital device-oriented composite end point (DOCE)
30 days
Secondary Outcomes (1)
DOCE
30 days
Interventions
Intravascular lithotripsy (IVL)
Eligibility Criteria
consecutive patients with stent underexpansion treated with intravascular lithotripsy (IVL)
You may qualify if:
- stent underexpansion treated with intravascular lithotripsy (IVL)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Silesialead
- Wojciech Wojakowskicollaborator
Study Sites (16)
Department of Invasive Cardiology, Medical University of Bialystok, The Medical University of Bialystok Clinical Hospital
Bialystok, Poland
First Department of Cardiology, Medical University of Gdansk
Gdansk, Poland
Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
Katowice, 40-635, Poland
Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
Krakow, Poland
Miedziowe Centrum Zdrowia S.A.
Lubin, Poland
Department of Cardiology, University Hospital, Institute of Medical Sciences
Opole, Poland
Department of Cardiology, Poznan University of Medical Sciences
Poznan, Poland
Department of Cardiology
Poznan, Poland
Department of Cardiology, The Ministry of Internal Affairs and Administration Hospital, Rzeszow
Rzeszów, Poland
1st Department of Cardiology, Medical University of Warsaw
Warsaw, Poland
Department of Cardiology and Internal Diseases, Military Institute of Medicine
Warsaw, Poland
Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland
Warsaw, Poland
Department of Invasive Cardiology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration
Warsaw, Poland
Department of Invasive Cardiology, Wejherowo
Wejherowo, Poland
Centre for Heart Disease, University Hospital Wroclaw Department of Heart Disease, Wroclaw Medical University
Wroclaw, Poland
Third Department of Cardiology, Medical University of Katowice
Zabrze, Poland
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
October 19, 2021
First Posted
November 8, 2021
Study Start
November 1, 2019
Primary Completion
April 1, 2021
Study Completion
April 1, 2021
Last Updated
November 8, 2021
Record last verified: 2021-11